{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:44:18Z","timestamp":1792842258376,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2215\/cjn.03270314","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T21:52:40Z","timestamp":1429048360000},"page":"1021-1030","source":"Crossref","is-referenced-by-count":67,"title":["Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism"],"prefix":"10.2215","volume":"10","author":[{"given":"Stuart M.","family":"Sprague","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Wetmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Da Roza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Buerkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-17-20230601","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R3-17-20230601","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrneph.2013.147","article-title":"FGF-23 and secondary hyperparathyroidism in chronic kidney disease.","volume":"9","author":"Silver","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R4-17-20230601","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands.","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R5-17-20230601","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MNH.0b013e328338f536","article-title":"Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.","volume":"19","author":"Zisman","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R6-17-20230601","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1359\/jbmr.090406","article-title":"Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men.","volume":"24","author":"Burnett-Bowie","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R7-17-20230601","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop.","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R8-17-20230601","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2011.107","article-title":"Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo.","volume":"80","author":"L\u00f3pez","year":"2011","journal-title":"Kidney Int"},{"key":"R9-17-20230601","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"R10-17-20230601","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: A potential role for PTH(7-84).","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-17-20230601","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R12-17-20230601","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat.","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int"},{"key":"R13-17-20230601","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R14-17-20230601","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1073\/pnas.0306141101","article-title":"Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones.","volume":"101","author":"Dvorak","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-17-20230601","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00774-008-0843-7","article-title":"The calcium-sensing receptor in bone.","volume":"26","author":"Yamaguchi","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"R16-17-20230601","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ndt\/gfu011","article-title":"Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: Results of the IMPACT-SHPT study.","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R17-17-20230601","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/ndt\/gfr668","article-title":"Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol.","volume":"27","author":"Hansen","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R18-17-20230601","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11255-011-0050-7","article-title":"Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism.","volume":"44","author":"Hryszko","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"R19-17-20230601","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2369-14-112","article-title":"Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: A randomized controlled study.","volume":"14","author":"Kim","year":"2013","journal-title":"BMC Nephrol"},{"key":"R20-17-20230601","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R21-17-20230601","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"key":"R22-17-20230601","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-17-20230601","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R24-17-20230601","doi-asserted-by":"crossref","first-page":"E652","DOI":"10.1210\/jc.2013-4050","article-title":"Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.","volume":"99","author":"Takahashi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-17-20230601","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/ndt\/gfs018","article-title":"Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: Results of the IMPACT SHPT study.","volume":"27","author":"Ketteler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R26-17-20230601","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1152\/ajpendo.00460.2012","article-title":"Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo.","volume":"304","author":"Quinn","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R28-17-20230601","doi-asserted-by":"crossref","first-page":"F1315","DOI":"10.1152\/ajprenal.00552.2009","article-title":"Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.","volume":"298","author":"Finch","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R29-17-20230601","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD.","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R30-17-20230601","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1159\/000319650","article-title":"Fibroblast growth factor 23 in hemodialysis patients: Effects of phosphate binder, calcitriol and calcium concentration in the dialysate.","volume":"117","author":"Cancela","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R31-17-20230601","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1093\/ndt\/gfr344","article-title":"Phosphate and FGF23 in early CKD: On how to tackle an invisible foe.","volume":"26","author":"Ketteler","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R32-17-20230601","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-17-20230601","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: A randomized clinical trial.","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R34-17-20230601","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5414\/CN107764","article-title":"The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.","volume":"80","author":"Soriano","year":"2013","journal-title":"Clin Nephrol"},{"key":"R35-17-20230601","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone.","volume":"154","author":"David","year":"2013","journal-title":"Endocrinology"},{"key":"R36-17-20230601","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: Assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism.","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:20Z","timestamp":1786369520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03270314","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}